CYIOS Corp. Appoints John O'Shea as Chief Executive Officer to Lead Next Phase of Growth and Innovation

Stock Information for ObsEva

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ObsEva

CYIOS Corporation LLC Appoints Atlanta Capital Partners, LLC for Investor Relations
CYIOS Corporation (OTC: CYIO) Announces Leadership Transition and Engages Artificial Intelligence (AI) and Software-as-a-Service (SaaS) advisors
Presenting on Emerging Growth Conference 84 Day 1 on July 16; Register to live stream
Presenting on Emerging Growth Conference 83 Day 2 on June 18; Register to live stream
Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream
CYIOS Corp Reports Record $5 Million in Q4 Revenue Through Noir Subsidiary; Noir Full-Year Revenue Exceeds $14.4 Million
Presenting on the Emerging Growth Conference 78 Day 1 on January 15 Register Now
NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.